SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-025131
Filing Date
2024-03-04
Accepted
2024-03-04 18:36:01
Documents
1
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3338
  Complete submission text file 0000950170-24-025131.txt   5053
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 23, GEURINTEKEU-RO, YEONGGWANG-EUP YEONGGWANG-GUN JEOLLANAM-DO M5 57024
Business Address 23, GEURINTEKEU-RO, YEONGGWANG-EUP YEONGGWANG-GUN JEOLLANAM-DO M5 57024 216-861-6697
DGP Co., Ltd. (Reporting) CIK: 0001982280 (see all company filings)

State of Incorp.: M5
Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 24717266